There are a lot of GLP-1s on the market: compounded semaglutide, Ozempic, Wegovy, Zepbound, Saxenda, Mounjaro the list goes on
The remaining 30% of UA traverses the intestines, where transport proteins and microbial metabolism collectively contribute to its elimination (Figure 1) [14, 15, 16]
Comparison at a Glance Who Should Consider Switching If you're currently using Eden Health for weight management, you might benefit from switching to FormBlends if: Not sure which GLP-1 is right for you
The STEP clinical trial series demonstrated that weekly semaglutide 2.4 mg achieved 16.8% average weight loss in patients with obesity but without diabetes over 68 weeks, significantly better than placebo
For patients and clinicians, this matters because it changes how we think about outcomes